Narrowing in on Compulsions: Dopamine Receptor Functions

Experimental and Clinical Psychopharmacology

Volumn 16, Issue 6, 2008, Pages 498-502

  Collins, Gregory T ^a   Woods, James H ^b  

^a Department of Pharmacology ^*

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

dopamine D2 receptor; dopamine D3 receptor; impulse control disorders; pramipexole

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; CJ 1037; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; L 741626; PG 01037; PRAMIPEXOLE; QUINPIROLE; UNCLASSIFIED DRUG;

COMPULSION; CORE TEMPERATURE; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFECT; DRUG SELF ADMINISTRATION; HYPOTHERMIA; IMPULSE CONTROL DISORDER; INSTRUMENTAL CONDITIONING; LOCOMOTION; NONHUMAN; RAT; REINFORCEMENT; REVIEW; REWARD; YAWNING;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; COMPULSIVE BEHAVIOR; CONDITIONING, OPERANT; QUINPIROLE; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; YAWNING;

EID: 57949083439     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0014190     Document Type: Review

References (14)

1. Amato D., Milella M.S., Badiani A., and Nencini P. Compulsive-like effects of repeated administration of quinpirole on drinking behavior in rats. Behavior & Brain Research 172 (2006) 1-13 Erratum in: Behavior & Brain Research. (2006). 175, 425-426
2. Chen, J., Collins, G. T., Zhang, J., Yang, C. Y., Levant, B., Woods, J., et al. (in press). Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile. Journal of Medicinal Chemistry
3. Collins G.T., Calinski D.M., Newman A.H., Grundt P., and Woods J.H. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: Evidence for sensitization of dopamine D2 receptor-mediated effects. Journal of Pharmacology & Experimental Therapeutics 325 (2008) 691-697
4. Collins G.T., Newman A.H., Grundt P., Rice K.C., Husbands S.M., Chauvignac C., et al. Yawning and hypothermia in rats: Effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology (Berl) 193 (2007) 159-170
5. Collins G.T., Witkin J.M., Newman A.H., Svensson K.A., Grundt P., Cao J., et al. Dopamine agonist-induced yawning in rats: A dopamine D3 receptor-mediated behavior. Journal of Pharmacology & Experimental Therapeutics 314 (2005) 310-319
6. Collins G.T., and Woods J.H. Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat. Journal of Pharmacology & Experimental Therapeutics 323 (2007) 599-605
7. Comer S.D., Sullivan M.A., and Hulse G.K. Sustained-release naltrexone: Novel treatment for opioid dependence. Expert Opinion on Investigational Drugs 16 (2007) 1285-1294
8. Di Ciano P., Underwood R.J., Hagan J.J., and Everitt B.J. Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 28 (2003) 329-338
9. Levant B. The D3 dopamine receptor: Neurobiology and potential clinical relevance. Pharmacological Review 49 (1997) 231-252
10. Nader M.A., and Mach R.H. Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology (Berl) 125 (1996) 13-22
11. Piercey M.F. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease. Clinical Neuropharmacology 21 (1998) 141-151
12. Spiller K., Xi Z.X., Peng X.Q., Newman A.H., Ashby Jr. C.R., Heidbreder C., et al. The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats. Psychopharmacology (Berl) 196 (2008) 533-542
13. Truong, N. Y., & Collins, G. T. (2008). [Cocaine-induced sensitization of dopamine D3-mediated effects in rats]. Unpublished raw data.
14. Voon V., and Fox S.H. Medication-related impulse control and repetitive behaviors in Parkinson disease. Archives of Neurology 64 (2007) 1089-1096